How omnichannel engagement boosted medication adherence by 15.5%

Pharmaceutical companies face challenges with patient adherence, especially among new prescription users. High void rates and "one-and-done" patterns harm treatment outcomes and business results, with many patients abandoning therapy after initial prescriptions.

This case study explores how a Fortune 500 life sciences manufacturer tackled these issues using an AI-enabled omnichannel platform to boost adherence for cholesterol-lowering medication. Results include:

· 40,000 patients reached via targeted messaging
· 27,000 incremental injections from better adherence
· 15.5% relative lift over control group outcomes

Read the full case study for the strategy and results.